Ysios Capital, a Spanish venture capital firm specialising in life sciences, today announced the launch of InceptionBio, a new fund…
Read More

Ysios Capital, a Spanish venture capital firm specialising in life sciences, today announced the launch of InceptionBio, a new fund…
Read More
Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into…
Read More
Sutro Biopharma was once worth $1 billion, another Bay Area biotech company with deep coffers and a novel research plan.…
Read More
Geron Corporation, a Bay Area biotech company that’s ramping up sales of its first commercial drug, announced on Thursday that…
Read More
Pliant Therapeutics, a South San Francisco biotech company developing treatments for fibrosis, is slashing its staff after halting a crucial…
Read More
Jasper Therapeutics started the year with 64 full-time employees and a robust valuation of more than $320 million. Just seven…
Read More
Alector, a once-high-flying Bay Area biotech company that researches treatments for degenerative brain disorders like Parkinson’s and Alzheimer’s diseases, is…
Read More
When Gossamer Bio announced poor results from its flagship blood pressure study in February, the San Diego company’s stock dropped…
Read More
Kiran Mazumdar-Shaw stands as one of India’s most influential business leaders, widely recognized for transforming the biotechnology landscape. As the…
Read More
Evogene Ltd stock (ISIN: IL0010831684) trades thinly on global exalters as the Israeli biotech pioneer advances AI platforms for sustainable…
Read More